Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Additionally we are shipping CD79a Molecule, Immunoglobulin-Associated alpha Proteins (12) and CD79a Molecule, Immunoglobulin-Associated alpha Kits (3) and many more products for this protein.
Showing 10 out of 536 products:
Human Monoclonal CD79A Primary Antibody for FACS, IHC (f) - ABIN1302907
Fuentes-Pananá, Bannish, van der Voort, King, Monroe: Ig alpha/Ig beta complexes generate signals for B cell development independent of selective plasma membrane compartmentalization. in Journal of immunology (Baltimore, Md. : 1950) 2005
Show all 10 references for 1302907
Human Monoclonal CD79A Primary Antibody for FACS, IHC (p) - ABIN1688087
Ganbat, Seehase, Richter, Vollmer, Reiling, Fellenberg, Gaede, Kugler, Goldmann: Mycobacteria infect different cell types in the human lung and cause species dependent cellular changes in infected cells. in BMC pulmonary medicine 2016
Show all 7 references for 1688087
Human Monoclonal CD79A Primary Antibody for IHC (p) - ABIN1688095
Kinoshita, Takasu, Kobayashi, Yuri, Tsubura, Shikata: Diagnosis of intraocular lesions using vitreous humor and intraocular perfusion fluid cytology: Experience with 83 Cases. in Diagnostic cytopathology 2015
Show all 6 references for 1688095
Human Monoclonal CD79A Primary Antibody for IHC (fro), IHC (p) - ABIN114588
Mason, van Noesel, Cordell, Comans-Bitter, Micklem, Tse, van Lier, van Dongen: The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation. in European journal of immunology 1992
Show all 4 references for 114588
Human Monoclonal CD79A Primary Antibody for EIA, FACS - ABIN319818
Zhang, French, Chan, OKeefe, Cragg, Power, Glennie: The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease. in Therapeutic immunology 1997
Show all 3 references for 319818
Human Monoclonal CD79A Primary Antibody for FACS - ABIN118795
Bell, Rooney, Bosanquet: CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase. in Cytometry 1999
Show all 2 references for 118795
Chicken Polyclonal CD79A Primary Antibody for IHC (fro), IHC (p) - ABIN115407
Hatada, Inazawa, Abe, Nakayama, Kaneko, Jinno, Niikawa, Ohashi, Fukushima, Iida, Yutani, Takahashi, Chiba, Ohishi, Mukai: Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors. in Human molecular genetics 1996
Cow (Bovine) Monoclonal CD79A Primary Antibody for FACS - ABIN316540
Jones, Cordell, Beyers, Tse, Mason: Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. in Journal of immunology (Baltimore, Md. : 1950) 1993
BCR (show BCR Antibodies) activation is accompanied by asymmetric conformational changes, possibly promoting the binding of Igalpha and Igbeta to differently localized signaling complexes
CD79a myeloid cells showed enhanced ability to promote primary tumor growth and metastasis.
Data indicate that in the absence of DGKzeta (show DGKZ Antibodies), the threshold for B cell antigen receptor (BCR (show BCR Antibodies)) signaling, measured as activation of the Ras-extracellular signal-regulated kinase (ERK (show EPHB2 Antibodies)) pathway, was markedly reduced in mature follicular B cells.
Data show that the B cell antigen receptor (BCR (show BCR Antibodies)) and Igalpha may be required for B cell survival because they function as adaptor proteins in a BAFFR (show TNFRSF13C Antibodies) signaling pathway leading to activation of Syk (show SYK Antibodies), indicating crosstalk between the two receptors.
The mouse B cell-specific mb-1 (show PSMB5 Antibodies) gene encodes an immunoreceptor tyrosine-based activation motif (ITAM) protein that may be evolutionarily conserved in diverse species by purifying selection.
endocytosed BCR (show BCR Antibodies) sequentially regulates MAPK (show MAPK1 Antibodies) and Akt (show AKT1 Antibodies) signaling pathways from intracellular compartments
Arginine 198 in the tail of the Igalpha subunit of the BCR (show BCR Antibodies) is methylated by the protein arginine methyltransferase 1 (show PRMT1 Antibodies). Methylation negatively regulates the calcium and PI-3 (show PI3 Antibodies) kinase pathways of the BCR (show BCR Antibodies), promoting signals leading to B (show TDO2 Antibodies) cell differentiation.
The direct recruitment of BLNK (show BLNK Antibodies) to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways
IgA deficiency in lymphotoxin-deficient (LT(-/-)) mice could be fully reversed by reconstitution with LT-expressing bone marrow, despite the absence of both LNs and PPs.
The VHDJH recombination process at the IgH locus and the survival of pro-B cells that carry these rearrangements do not depend on the expression of Ig-alpha molecules.
The incidence of MYD88 (show MYD88 Antibodies) and CD79B (show CD79B Antibodies) mutations in patients with CD5 (show CD5 Antibodies)(+) DLBCL is lower than that in patients with DLBCL-SS, suggesting that CD5 (show CD5 Antibodies)(+) DLBCL is not the same disease as DLBCL-SS in terms of gene mutation status.
Data show that Bruton tyrosine kinase (BTK (show BTK Antibodies))inhibitor Ibrutinib augments MALT lymphoma associated translocation (show MALT1 Antibodies) protein (MALT1 (show MALT1 Antibodies)) inhibition by S-Mepazine in CD79 antigen mutant activated B cell-subtype (ABC (show ABCB6 Antibodies)) of diffuse large B cell lymphoma (DLBCL).
Phosphorylation of CD79a causes a decrease in helical propensity in the C-terminal region, for CD79b (show CD79B Antibodies), the opposite was observed and phosphorylation resulted in an increase of helical propensity in the C-terminal part.
High intensity of caries is associated with increased levels of some salivary components - sIgA, histatin-5 (show HTN3 Antibodies) and lactoperoxidase (show LPO Antibodies).
CD79a plays a functional role in the tumor promoting effects of myeloid cells, and may represent a novel target for cancer therapy.
STN (show EEF1A2 Antibodies) produced significant antitumor effects in a mouse xenograft model of CD79A/B-mutated DLBCL.
CD79a may be helpful marker in the differential diagnosis of classical Hodgkin's lymphoma and primary mediastinal B-cell lymphoma
Unlike the B29 (show CD79B Antibodies) octamer motif, the mb-1 (show PSMB5 Antibodies) octamer motif does not have the essential sequence required for OBF-1/Bob1 (show POU2AF1 Antibodies) interaction, therefore its promoter is not transactivated by OBF-1/Bob1 (show POU2AF1 Antibodies).
B cell-restricted mb-1 (show PSMB5 Antibodies) gene: expression, function, and lineage infidelity. Review.
Results indicate that PAX5 (show PAX5 Antibodies) is a more specific marker than CD79a for B-cell ALL diagnosis.
The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-alpha protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described.
CD79a molecule, immunoglobulin-associated alpha
, B-cell antigen receptor complex-associated protein alpha chain
, Ig alpha
, MB-1 membrane glycoprotein
, immunoglobulin-associated alpha
, membrane-bound immunoglobulin-associated protein
, surface IgM-associated protein
, CD79a antigen (immunoglobulin-associated alpha)
, CD79-alpha protein
, CD79A antigen (immunoglobulin-associated alpha)
, B-cell antigen receptor complex-associated protein alpha-chain